Kuwait - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Kuwait Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases fell by 2.3% year on year. In 2019, the country was ranked number 263 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 8 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.

Loading...

Date Units (Cases)
2019 8.00
2018 8.00
2017 6.00
2016 11.00
2015 10.00
Download all data from 2005 to 2019

How does Kuwait rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
263 #263
Czech Republic
8 2019 -33.3 % +0.0 % View data
263 #263
Kuwait
8 2019 +0.0 % -2.3 % View data
270 #270
Finland
7 2019 +16.7 % -2.6 % View data
Compare all 359 countries

Go Top